PIN4 Prostate Triple Stain by Immunohistochemistry
Also known as: PIN4 IHC
Use
The PIN4 Prostate Triple Stain by Immunohistochemistry is utilized in the evaluation of prostate tissue. This test helps in the differential diagnosis of prostate cancer by assessing the presence or absence of specific markers such as p504S, p63, and 34βE12. It aims to distinguish between benign and malignant prostate tissues, providing valuable information for clinical decision-making.
Special Instructions
Not provided.
Limitations
The test is a Laboratory Developed Test (LDT) and has not been cleared or approved by the FDA. It is intended for clinical purposes and performed in a CLIA certified laboratory. Test results should be interpreted in the context of the patient's clinical and pathological data, and by a qualified healthcare professional. The accuracy of this test is dependent on the quality and representativeness of the submitted tissue specimen.
New York Approved
Methodology
Immunoassay (IHC)
Biomarkers
34βE12
Proteinp504S
Proteinp63
Protein
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
2 slides
Container
Tissue block or 5 unstained, positively charged slides
Collection Instructions
Formalin fix (10 percent neutral buffered formalin) and paraffin embed specimen (cells must be prepared into a cellblock). Protect paraffin block and/or slides from excessive heat.
Storage Instructions
Transport at room temperature. Refrigerated shipping is also acceptable during summer months.
Causes for Rejection
Specimens submitted with non-representative tissue type. Depleted specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Indefinitely |
| Refrigerated | Indefinitely |
| Frozen | Unacceptable |
Other tests from different labs that may be relevant